269 related articles for article (PubMed ID: 38301482)
1. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Le Marchand L; Phipps AI; Buchanan DD; ; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Davey Smith G; Brennan P; Herzig KH; Järvelin MR; Amos CI; Hung RJ; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
EBioMedicine; 2024 Feb; 100():104991. PubMed ID: 38301482
[TBL] [Abstract][Full Text] [Related]
2. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky J; Robinson JW; Mariosa D; Karhunen V; Huang J; Dimou N; Murphy N; Burrows K; Bouras E; Smith-Byrne K; Lewis SJ; Galesloot TE; Kiemeney LA; Vermeulen S; Martin P; Albanes D; Hou L; Newcomb PA; White E; Wolk A; Wu AH; Marchand LL; Phipps AI; Buchanan DD; ; Zhao SS; Gill D; Chanock SJ; Purdue MP; Smith GD; Brennan P; Herzig KH; Jarvelin MR; Dehghan A; Johansson M; Gunter MJ; Tsilidis KK; Martin RM
medRxiv; 2023 May; ():. PubMed ID: 37205426
[TBL] [Abstract][Full Text] [Related]
3. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
Elife; 2022 Mar; 11():. PubMed ID: 35346416
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
5. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
6. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
7. The association between genetically elevated polyunsaturated fatty acids and risk of cancer.
Haycock PC; Borges MC; Burrows K; Lemaitre RN; Burgess S; Khankari NK; Tsilidis KK; Gaunt TR; Hemani G; Zheng J; Truong T; Birmann BM; OMara T; Spurdle AB; Iles MM; Law MH; Slager SL; Saberi Hosnijeh F; Mariosa D; Cotterchio M; Cerhan JR; Peters U; Enroth S; Gharahkhani P; Le Marchand L; Williams AC; Block RC; ; ; ; ; ; ; ; ; ; ; Amos CI; Hung RJ; Zheng W; Gunter MJ; Smith GD; Relton C; Martin RM;
EBioMedicine; 2023 May; 91():104510. PubMed ID: 37086649
[TBL] [Abstract][Full Text] [Related]
8. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
9. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
10. Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study.
Fu Y; Xu F; Jiang L; Miao Z; Liang X; Yang J; Larsson SC; Zheng JS
BMC Med; 2021 Jul; 19(1):171. PubMed ID: 34325683
[TBL] [Abstract][Full Text] [Related]
11. Modifiable pathways for colorectal cancer: a mendelian randomisation analysis.
Cornish AJ; Law PJ; Timofeeva M; Palin K; Farrington SM; Palles C; Jenkins MA; Casey G; Brenner H; Chang-Claude J; Hoffmeister M; Kirac I; Maughan T; Brezina S; Gsur A; Cheadle JP; Aaltonen LA; Tomlinson I; Dunlop MG; Houlston RS
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):55-62. PubMed ID: 31668584
[TBL] [Abstract][Full Text] [Related]
12. Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk.
Robinson T; Martin RM; Yarmolinsky J
Int J Cancer; 2020 Sep; 147(6):1597-1603. PubMed ID: 32134113
[TBL] [Abstract][Full Text] [Related]
13. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.
Bouras E; Karhunen V; Gill D; Huang J; Haycock PC; Gunter MJ; Johansson M; Brennan P; Key T; Lewis SJ; Martin RM; Murphy N; Platz EA; Travis R; Yarmolinsky J; Zuber V; Martin P; Katsoulis M; Freisling H; Nøst TH; Schulze MB; Dossus L; Hung RJ; Amos CI; Ahola-Olli A; Palaniswamy S; Männikkö M; Auvinen J; Herzig KH; Keinänen-Kiukaanniemi S; Lehtimäki T; Salomaa V; Raitakari O; Salmi M; Jalkanen S; ; Jarvelin MR; Dehghan A; Tsilidis KK
BMC Med; 2022 Jan; 20(1):3. PubMed ID: 35012533
[TBL] [Abstract][Full Text] [Related]
14. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.
Hazelwood E; Sanderson E; Tan VY; Ruth KS; Frayling TM; Dimou N; Gunter MJ; Dossus L; Newton C; Ryan N; Pournaras DJ; O'Mara TA; Davey Smith G; Martin RM; Yarmolinsky J
BMC Med; 2022 Apr; 20(1):125. PubMed ID: 35436960
[TBL] [Abstract][Full Text] [Related]
15. Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts.
Caramaschi D; Jungius J; Page CM; Novakovic B; Saffery R; Halliday J; Lewis S; Magnus MC; London SJ; Håberg SE; Relton CL; Lawlor DA; Elliott HR
Hum Reprod; 2021 Jul; 36(8):2403-2413. PubMed ID: 34136910
[TBL] [Abstract][Full Text] [Related]
16. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
17. Atopic dermatitis and risk of 14 site-specific cancers: A Mendelian randomization study.
Liu Q; Chen L; Wang Y; Wang X; Lewis SJ; Wang J
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2490-2497. PubMed ID: 37478287
[TBL] [Abstract][Full Text] [Related]
18. Investigating Causal Associations of Diet-Derived Circulating Antioxidants with the Risk of Digestive System Cancers: A Mendelian Randomization Study.
Zhang X; Zhao H; Man J; Yin X; Zhang T; Yang X; Lu M
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956413
[TBL] [Abstract][Full Text] [Related]
19. A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.
Bottigliengo D; Foco L; Seibler P; Klein C; König IR; Del Greco M F
Brain; 2022 Oct; 145(10):3444-3453. PubMed ID: 35656776
[TBL] [Abstract][Full Text] [Related]
20. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
